Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.

Autor: Hoashi T; Department of Dermatology, Nippon Medical School, Tokyo, Japan., Ishikawa M; Department of Dermatology, Saitama Cancer Center, Saitama, Japan., Uehara J; Department of Dermatologic Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Oashi K; Department of Dermatology, Saitama Cancer Center, Saitama, Japan., Maeda S; Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan., Kato J; Department of Dermatology, Sapporo Medical University, Sapporo, Japan., Saruta H; Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan., Shichinohe R; Department of Plastic and Reconstructive Surgery, Teine Keijinkai Hospital, Sapporo, Japan., Ohashi R; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Nakamura Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Koga H; Department of Dermatology, Shinshu University, Matsumoto, Japan., Sugaya M; Department of Dermatology, International University of Health and Welfare, Narita, Japan.

Publikováno v: The Journal of dermatology [J Dermatol] 2024 Apr; Vol. 51 (4), pp. e90-e105. Date of Electronic Publication: 2024 Jan 24.

THE AUTHORS' ANSWER TO DISCUSSION BY MR. HIROSHI UEHARA : Hiroshi UEHARA, J. Struct. Constr. Eng., AIJ, No.516, 181-182, Feb. 1999

Autor: Katsuki Takiguchi, Noriyuki Ogura, Shaomei Mu

Publikováno v: Journal of Structural and Construction Engineering (Transactions of AIJ). 64:183-184

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4b66c8df20845177fbe1cb6ae0c6594
https://doi.org/10.3130/aijs.64.183

Neutrophil-to-lymphocyte ratio is a potential prognostic biomarker for extramammary Paget disease: A retrospective study.

Autor: Maeda T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Toyoshima R; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Nakagawa T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Publikováno v: The Journal of dermatology [J Dermatol] 2022 Nov; Vol. 49 (11), pp. 1188-1192. Date of Electronic Publication: 2022 Jul 29.

Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience.

Autor: Maeda T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Nagai K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Toyoshima R; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Nakagawa T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Publikováno v: The Journal of dermatology [J Dermatol] 2023 Jan; Vol. 50 (1), pp. 57-63. Date of Electronic Publication: 2022 Oct 11.

Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study.

Autor: Kato J; Department of Dermatology, Sapporo Medical University, Sapporo, Japan., Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan., Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan., Nomura M; Department of Clinical Oncology, Kyoto University, Kyoto, Japan., Nakamura Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan., Uhara H; Department of Dermatology, Sapporo Medical University, Sapporo, Japan., Uchi H; Department of Dermato-Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Yoshikawa S; Dermatology Division, Shizuoka Cancer Center, Shizuoka, Japan., Kiniwa Y; Department of Dermatology, Shinshu University, Nagano, Japan., Nakamura Y; Department of Dermatology, University of Tsukuba, Tsukuba, Japan., Miyagawa T; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan., Matsushita S; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan., Takenouchi T; Department of Dermatology, Niigata Cancer Center, Niigata, Japan., Hatta N; Department of Dermatology, Toyama Prefectural Central Hospital, Toyama, Japan., Ohno F; Department of Dermatology, Kyushu University, Fukuoka, Japan., Maeda T; Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Fukushima S; Department of Dermatology and Plastic Surgery, Kumamoto University, Kumamoto, Japan., Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2022 Oct; Vol. 187 (4), pp. 594-596. Date of Electronic Publication: 2022 Jun 07.